- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Nasdaq
Wall Street JournalEN
A
APLS
Apellis Pharmace
22.28
-0.52-2.28%After Hours: 22.28 0.00 0.00%16:10 02/20 EST
OPEN/PREV CLOSE22.81/22.80
TODAY RANGE22.08-22.81
VOL1.51M
MARKET CAP2.82B
52 WEEK RANGE16.10-30.48
AVG VOL (3M)2.79M
% TURNOVER1.19%
TURNOVER--
P/E (TTM)75.02
% RANGE3.20%
EPS(TTM)0.2970
P/E(FORWARD)92.83
P/B7.03
BVPS3.171
DIVIDEND--
P/S3.550
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.37B
SHARES OUTSTANDING126.53M
NEXT EARNINGS02/26-03/02
FREE FLOAT106.16M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·3d ago
Assessing Apellis Pharmaceuticals (APLS) Valuation After Mixed Returns And High P/E Versus DCF Fair Value Estimate
Simply Wall St·02/11 18:30
Is It Time To Reassess Apellis Pharmaceuticals (APLS) After The Recent Share Price Slide
NASDAQ·02/11 16:52
APLS Makes Notable Cross Below Critical Moving Average
Reuters·02/10 12:00
Apellis Pharmaceuticals Inc. kündigt Finanz-Update an
TipRanks·02/09 11:20
Short Report: VNET Group short interest at 4-month high
Simply Wall St·02/07 18:10
Broad S&P Index Inclusion Might Change The Case For Investing In Apellis Pharmaceuticals (APLS)
Simply Wall St·02/06 04:31
A Look At Apellis Pharmaceuticals (APLS) Valuation After Recent S&P Index Additions
NASDAQ·02/03 15:00
5 Drug/Biotech Stocks Likely to Outperform Q4 Earnings Estimates
TipRanks·02/03 07:26
Barclays Keeps Their Hold Rating on Apellis Pharmaceuticals (APLS)
Simply Wall St·01/31 08:33
How Empaveli’s Rapid Uptake and Q4 2025 Revenue Momentum Will Impact Apellis Pharmaceuticals (APLS) Investors
Simply Wall St·01/30 02:39
Apellis Pharmaceuticals (APLS) Valuation Check As Shares Trade Around US$23 After Mixed Return Performance
Benzinga·01/28 13:41
This Oklo Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday
Same Industry
Name/Symbol
Change%
Price